Maas Biolab Overview

  • Founded
  • 1997
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.38M
Latest Deal Amount
  • Investors
  • 4

Maas Biolab General Information


Operator of a biotechnology firm intended to develop a neuro-pharmaceutical drug. The company is developing a treatment for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, alzheimer's, parkinson's and huntington's, enabling healthcare practitioners to access advanced drugs for better treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 23 Abanico Road
  • Santa Fe, NM 87508
  • United States
+1 (505) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Maas Biolab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2007 $2.38M 0000 Completed Generating Revenue
1. Later Stage VC 25-Apr-2006 0000 0000 Completed Generating Revenue
To view Maas Biolab’s complete valuation and funding history, request access »

Maas Biolab Executive Team (3)

Name Title Board Seat Contact Info
Marcus Keep MD Chief Executive Officer & President
Michael Vickers Director of Operations
Eskil Elmér Founder
To view Maas Biolab’s complete executive team members history, request access »

Maas Biolab Board Members (1)

Name Representing Role Since
Cesar Borlongan Ph.D Self Chairman 000 0000
To view Maas Biolab’s complete board members history, request access »

Maas Biolab Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Maas Biolab Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National institutes of Neurological Disorders and Stroke Other 000 0000 000000 0
Small Business Innovation Research and Small Business Technology Transfer Programs Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
To view Maas Biolab’s complete investors history, request access »